| May 23 2024 |
Prime Time for Prime Hydration: YouTubers Clash With PFAS Regulations |
ArentFox Schiff LLP |
| May 23 2024 |
Testing Negative: Collateral Order Doctrine Precludes Appellate Jurisdiction |
McDermott Will & Schulte LLP |
| May 22 2024 |
Recent Regulatory Actions Against Unlicensed Pharmacy Benefit Managers in West Virginia |
Polsinelli PC |
| May 22 2024 |
Senators Propose Heavy Metal Legislation with Product Testing Requirements |
Keller and Heckman LLP |
| May 22 2024 |
Proposed Marijuana Reclassification and Impact on Employers |
Greenberg Traurig, LLP |
| May 22 2024 |
Master of Its Choice of Forum? |
Foley & Lardner LLP |
| May 22 2024 |
Department of Justice Publishes Notice of Proposed Rulemaking to Reschedule Marijuana to Schedule III |
Jackson Lewis P.C. |
| May 21 2024 |
IRC Section 280E Will No Longer Apply if Marijuana Is Rescheduled |
McDermott Will & Schulte LLP |
| May 21 2024 |
This Week in 340B: May 14 – May 20, 2024 |
McDermott Will & Schulte LLP |
| May 21 2024 |
Employee Mobility and Trade Secrets in the Golden Era of Life Sciences Innovation |
Proskauer Rose LLP |
| May 21 2024 |
Iowa Governor Signs ‘Meat Integrity Bill’ |
Keller and Heckman LLP |
| May 20 2024 |
MA and CT Pave the Way for Emergency Contraception Vending Machines |
Robinson & Cole LLP |
| May 20 2024 |
Healthcare Preview for the Week of: May 20, 2024 [Podcast] |
McDermott Will & Schulte LLP |
| May 20 2024 |
LDTs: FDA Rolls Out a Phased Implementation for New Regulatory Requirements |
Foley & Lardner LLP |
| May 17 2024 |
McDermottPlus Check-Up: May 17, 2024 |
McDermott Will & Schulte LLP |
| May 17 2024 |
DOJ Confirms Moving Marijuana to Schedule III; Sidesteps Anticipated Impact on State Cannabis Markets |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| May 17 2024 |
White Smoke: Habemus Proposed Rule Making on Marijuana Rescheduling! |
Bradley Arant Boult Cummings LLP |
| May 16 2024 |
Imported Drugs: (Possibly) Coming Soon to a State Near You |
McDermott Will & Schulte LLP |
| May 16 2024 |
Alabama Bans Sale of Cultured Meat, Following Florida |
Keller and Heckman LLP |
| May 16 2024 |
EPA, FDA, and USDA Issue Joint Regulatory Plan for Biotechnology |
Bergeson & Campbell, P.C. |
| May 15 2024 |
Keeping Track of Your Data — What You Need to Know about FDA’s Draft Guidance on Data Integrity for In Vivo Bioavailability and Bioequivalence Studies |
Foley & Lardner LLP |
| May 15 2024 |
This Week in 340B: May 7 – May 13, 2024 |
McDermott Will & Schulte LLP |
| May 15 2024 |
FDA Concludes that Tara Flour is Not GRAS |
Keller and Heckman LLP |
| May 15 2024 |
Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel Medications |
McDermott Will & Schulte LLP |
| May 15 2024 |
Some Judges Have — Naturally — Grown Skeptical of False Advertising Class Actions Challenging “Natural” Labels |
Foley & Lardner LLP |
| May 14 2024 |
Dollar Tree Sued Over Lead-Contaminated Cinnamon |
Keller and Heckman LLP |
| May 14 2024 |
Litigating Nutrition: Class Action Battles Over Dietary Supplements [Podcast, Video] |
Epstein Becker & Green, P.C. |
| May 14 2024 |
New ADR Rule to Govern Disputes Between 340B Covered Entities and Drug Manufacturers |
ArentFox Schiff LLP |
| May 13 2024 |
The Menthol Cigarette Ban Saga: Biden Administration Delays Long-Anticipated Ban Indefinitely |
Keller and Heckman LLP |
| May 13 2024 |
EPA, USDA, and FDA to Clarify Overlapping Biotechnology Regulatory Frameworks |
Beveridge & Diamond PC |
| May 10 2024 |
McDermottPlus Check-Up: May 10, 2024 |
McDermott Will & Schulte LLP |
| May 10 2024 |
FDA Issues Final Rule to Regulate Laboratory-Developed Tests as Medical Devices |
Greenberg Traurig, LLP |
| May 10 2024 |
Florida Bans Cultivated Animal Cell Products |
Womble Bond Dickinson (US) LLP |
| May 9 2024 |
Bridging the Gap: Cannabis Rescheduling to Align Policy with Research |
Sheppard, Mullin, Richter & Hampton LLP |
| May 9 2024 |
USDA, FDA, EPA Release Joint Regulatory Plan for Biotechnology |
Keller and Heckman LLP |
